RIO DE JANEIRO, BRAZIL - Chinese vaccine maker Sinovac Biotech could have the results of its experimental COVID-19 vaccine from late-stage clinical trials as soon as next month, an executive said on Friday, November 20th.
Sinovac’s CoronaVac is in large late-stage trials in Brazil, Indonesia and Turkey. Preliminary results of early to mid-stage trials showed this week that it triggered a quick immune response but lower levels of antibodies than those seen in people who have recovered from COVID-19.
“Phase III is now running quite well,” Weining Meng, senior director of Sinovac, told the Global . . .